Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Molecular determinants of alphavirus neuropathogenesis in mice.

Atkins GJ, Sheahan BJ.

J Gen Virol. 2016 Jun;97(6):1283-1296. doi: 10.1099/jgv.0.000467. Epub 2016 Mar 30. Review.

PMID:
27028153
2.

The area under the curve of L-lactate in neonatal foals from birth to 14 days of age.

Sheahan BJ, Wilkins PA, Lascola KM, Martin V, Po E.

J Vet Emerg Crit Care (San Antonio). 2016 Mar-Apr;26(2):305-9. doi: 10.1111/vec.12419. Epub 2015 Nov 23.

PMID:
26595884
3.

Preliminary investigation of the area under the L-lactate concentration-time curve (LACArea) in critically ill equine neonates.

Wilkins PA, Sheahan BJ, Vander Werf KA, Castagnetti C, Hardy J, Schoster A, Boston RC.

J Vet Intern Med. 2015 Mar-Apr;29(2):659-62. doi: 10.1111/jvim.12559.

4.

Semliki Forest virus-mediated gene therapy of the RG2 rat glioma.

Roche FP, Sheahan BJ, O'Mara SM, Atkins GJ.

Neuropathol Appl Neurobiol. 2010 Dec;36(7):648-60. doi: 10.1111/j.1365-2990.2010.01110.x.

PMID:
20649937
5.

Electroporation of RNA stimulates immunity to an encoded reporter gene in mice.

Piggott JM, Sheahan BJ, Soden DM, O'Sullivan GC, Atkins GJ.

Mol Med Rep. 2009 Sep-Oct;2(5):753-6. doi: 10.3892/mmr_00000168.

PMID:
21475897
6.

Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model.

Logue CH, Bosio CF, Welte T, Keene KM, Ledermann JP, Phillips A, Sheahan BJ, Pierro DJ, Marlenee N, Brault AC, Bosio CM, Singh AJ, Powers AM, Olson KE.

J Gen Virol. 2009 Aug;90(Pt 8):1848-58. doi: 10.1099/vir.0.008656-0. Epub 2009 Apr 29.

7.

Therapeutic and prophylactic applications of alphavirus vectors.

Atkins GJ, Fleeton MN, Sheahan BJ.

Expert Rev Mol Med. 2008 Nov 11;10:e33. doi: 10.1017/S1462399408000859. Review.

PMID:
19000329
9.

The 5' untranslated region as a pathogenicity determinant of Semliki Forest virus in mice.

Logue CH, Sheahan BJ, Atkins GJ.

Virus Genes. 2008 Apr;36(2):313-21. doi: 10.1007/s11262-008-0209-1. Epub 2008 Feb 9.

PMID:
18264748
10.

Semliki Forest virus vectors expressing the H and HN genes of measles and mumps viruses reduce immunity induced by the envelope protein genes of rubella virus.

Callagy SJ, Kelly BJ, Fleeton MN, Sheahan BJ, Galbraith SE, Atkins GJ.

Vaccine. 2007 Oct 23;25(43):7481-90. Epub 2007 Sep 14.

PMID:
17905485
11.

Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice.

Lyons JA, Sheahan BJ, Galbraith SE, Mehra R, Atkins GJ, Fleeton MN.

Gene Ther. 2007 Mar;14(6):503-13. Epub 2006 Dec 14.

PMID:
17167497
12.

Inhibition of murine K-BALB and CT26 tumour growth using a Semliki Forest virus vector with enhanced expression of IL-18.

Chikkanna-Gowda CP, McNally S, Sheahan BJ, Fleeton MN, Atkins GJ.

Oncol Rep. 2006 Oct;16(4):713-9.

PMID:
16969484
13.

Deletions in the hypervariable domain of the nsP3 gene attenuate Semliki Forest virus virulence.

Galbraith SE, Sheahan BJ, Atkins GJ.

J Gen Virol. 2006 Apr;87(Pt 4):937-47.

PMID:
16528043
14.

The pyrrolo-1,5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status and inhibits breast tumour growth in vivo.

Greene LM, Fleeton M, Mulligan J, Gowda C, Sheahan BJ, Atkins GJ, Campiani G, Nacci V, Lawler M, Williams DC, Zisterer DM.

Oncol Rep. 2005 Nov;14(5):1357-63.

PMID:
16211309
15.
16.

Alphaviruses and their derived vectors as anti-tumor agents.

Atkins GJ, Smyth JW, Fleeton MN, Galbraith SE, Sheahan BJ.

Curr Cancer Drug Targets. 2004 Nov;4(7):597-607. Review.

PMID:
15578917
17.

Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector.

Smyth JW, Fleeton MN, Sheahan BJ, Atkins GJ.

Gene Ther. 2005 Jan;12(2):147-59.

PMID:
15372069
18.

Calcospherite-like bodies and caseous necrosis in tracheal mucus from a dog with tuberculosis.

Bauer NB, O'Neill E, Sheahan BJ, Cassidy J, McAllister H.

Vet Clin Pathol. 2004;33(3):168-72.

PMID:
15334354
20.

Role of interferon-gamma and nitric oxide in the neuropathogenesis of avirulent Semliki Forest virus infection.

Keogh B, Atkins GJ, Mills KH, Sheahan BJ.

Neuropathol Appl Neurobiol. 2003 Dec;29(6):553-62.

PMID:
14636162
21.
23.

The pathogenicity of louping ill virus for mice and lambs.

Sheahan BJ, Moore M, Atkins GJ.

J Comp Pathol. 2002 Feb-Apr;126(2-3):137-46.

PMID:
11945002
24.
25.

Progressive encephalomyelopathy and cerebellar degeneration in 10 captive-bred cheetahs.

Palmer AC, Callanan JJ, Guerin LA, Sheahan BJ, Stronach N, Franklin RJ.

Vet Rec. 2001 Jul 14;149(2):49-54.

PMID:
11488342
26.

A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model.

Morris-Downes MM, Sheahan BJ, Fleeton MN, Liljeström P, Reid HW, Atkins GJ.

Vaccine. 2001 Jul 16;19(28-29):3877-84.

PMID:
11427261
27.

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.

Morris-Downes MM, Phenix KV, Smyth J, Sheahan BJ, Lileqvist S, Mooney DA, Liljeström P, Todd D, Atkins GJ.

Vaccine. 2001 Feb 28;19(15-16):1978-88.

PMID:
11228368
28.

Transient virus infection and multiple sclerosis.

Atkins GJ, McQuaid S, Morris-Downes MM, Galbraith SE, Amor S, Cosby SL, Sheahan BJ.

Rev Med Virol. 2000 Sep-Oct;10(5):291-303. Review.

PMID:
11015741
29.

Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles.

Murphy AM, Morris-Downes MM, Sheahan BJ, Atkins GJ.

Gene Ther. 2000 Sep;7(17):1477-82.

31.

The molecular pathogenesis of Semliki Forest virus: a model virus made useful?

Atkins GJ, Sheahan BJ, Liljeström P.

J Gen Virol. 1999 Sep;80 ( Pt 9):2287-97. Review. No abstract available.

PMID:
10501479
32.

Cell death mechanisms in the olfactory bulb of rats infected intranasally with Semliki forest virus.

Sammin DJ, Butler D, Atkins GJ, Sheahan BJ.

Neuropathol Appl Neurobiol. 1999 Jun;25(3):236-43.

PMID:
10417665
33.

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.

Fleeton MN, Sheahan BJ, Gould EA, Atkins GJ, Liljeström P.

J Gen Virol. 1999 May;80 ( Pt 5):1189-98.

PMID:
10355766
34.

The Semliki Forest virus vector induces p53-independent apoptosis.

Glasgow GM, McGee MM, Tarbatt CJ, Mooney DA, Sheahan BJ, Atkins GJ.

J Gen Virol. 1998 Oct;79 ( Pt 10):2405-10.

PMID:
9780045
36.

Death mechanisms in cultured cells infected by Semliki Forest virus.

Glasgow GM, McGee MM, Sheahan BJ, Atkins GJ.

J Gen Virol. 1997 Jul;78 ( Pt 7):1559-63.

PMID:
9225029
37.

Sequence analysis of the avirulent, demyelinating A7 strain of Semliki Forest virus.

Tarbatt CJ, Glasgow GM, Mooney DA, Sheahan BJ, Atkins GJ.

J Gen Virol. 1997 Jul;78 ( Pt 7):1551-7.

PMID:
9225028
38.

Long-term effects of Semliki Forest virus infection in the mouse central nervous system.

Donnelly SM, Sheahan BJ, Atkins GJ.

Neuropathol Appl Neurobiol. 1997 Jun;23(3):235-41.

PMID:
9223133
39.

Morphometric analysis of growth retardation in fetal lambs following experimental infection of pregnant ewes with border disease virus.

Caffrey JF, Dudgeon AM, Donnelly WJ, Sheahan BJ, Atkins GJ.

Res Vet Sci. 1997 May-Jun;62(3):245-8.

PMID:
9300542
40.

Colocalisation of human immunodeficiency virus and human cytomegalovirus infection in brain autopsy tissue from AIDS patients.

Balluz IM, Farrell MA, Kay E, Staunton MJ, Keating JN, Sheils O, Cosby SL, Mabruk MJ, Sheahan BJ, Atkins GJ.

Ir J Med Sci. 1996 Apr-Jun;165(2):133-8.

PMID:
8698561
41.

Encephalitis and mass mortality of farmed salmon smolts in an isolated sea bay in Ireland.

Scullion FT, Scullion MG, Sparrow D, Rodger HD, Sheahan BJ.

Vet Rec. 1996 Feb 17;138(7):161-2. No abstract available.

PMID:
8677607
42.

Manipulation of the Semliki Forest virus genome and its potential for vaccine construction.

Atkins GJ, Sheahan BJ, Liljeström P.

Mol Biotechnol. 1996 Feb;5(1):33-8. Review.

PMID:
8853014
43.

Analysis of the molecular basis of neuropathogenesis of RNA viruses in experimental animals: relevance for human disease?

Atkins GJ, Balluz IM, Glasgow GM, Mabruk MJ, Natale VA, Smyth JM, Sheahan BJ.

Neuropathol Appl Neurobiol. 1994 Apr;20(2):91-102. Review.

PMID:
8072672
44.

A single amino acid change in the E2 spike protein of a virulent strain of Semliki Forest virus attenuates pathogenicity.

Glasgow GM, Killen HM, Liljeström P, Sheahan BJ, Atkins GJ.

J Gen Virol. 1994 Mar;75 ( Pt 3):663-8.

PMID:
8126464
45.

Effect of infection with rubella virus on the development of rat cerebellar cells in culture.

Natale VA, Caffrey JF, Sheahan BJ, Atkins GJ.

Neuropathol Appl Neurobiol. 1993 Dec;19(6):530-4.

PMID:
8121545
46.

Semliki Forest virus expression system: production of conditionally infectious recombinant particles.

Berglund P, Sjöberg M, Garoff H, Atkins GJ, Sheahan BJ, Liljeström P.

Biotechnology (N Y). 1993 Aug;11(8):916-20.

PMID:
7688971
47.
48.

Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice.

Glasgow GM, Sheahan BJ, Atkins GJ, Wahlberg JM, Salminen A, Liljeström P.

Virology. 1991 Dec;185(2):741-8.

PMID:
1660202
49.

Multiplication of rubella and measles viruses in primary rat neural cell cultures: relevance to a postulated triggering mechanism for multiple sclerosis.

Atkins GJ, Mooney DA, Fahy DA, Ng SH, Sheahan BJ.

Neuropathol Appl Neurobiol. 1991 Aug;17(4):299-308.

PMID:
1719441
50.

Structural and biochemical changes in a spinal myelinopathy in twelve English foxhounds and two harriers.

Sheahan BJ, Caffrey JF, Gunn HM, Keating JN.

Vet Pathol. 1991 Mar;28(2):117-24.

PMID:
2063513

Supplemental Content

Loading ...
Support Center